Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 741 Jan 1 – Oct 24, 2026
- Disclosed funding
- $25.3B 605 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| GP Gilgamesh PharmaCompany profile Develops novel chemical entities for psychiatric and neurological disorders Develops novel chemical entities for psychiatric and neurological disorders | $60M | Series A | Healthtech, Biotech | United States | Investors | |
| D DoctronicCompany profile Provides AI-powered personalized health insights and connects users to licensed providers instantly Provides AI-powered personalized health insights and connects users to licensed providers instantly | $40M | Series B | Healthtech | United States | Investors | |
| N NanoZymeXCompany profile NanoZymeX develops a lipid-nanoparticle platform for enzyme replacement therapy. NanoZymeX develops a lipid-nanoparticle platform for enzyme replacement therapy. | €160K | Pre-SeedPre-seed | Healthtech, Biotech | Switzerland | Investors | |
| ET Develops novel therapies for beta globin disorders | $32M | GrantUndisclosed | Healthtech, Biotech | United States | Investors | |
| AT Amani TherapeuticsCompany profile Biotechnology company developing combination medicines for serious neuropsychiatric disorders. Biotechnology company developing combination medicines for serious neuropsychiatric disorders. | $25M | Series A | Healthtech, Biotech | United States | Investors | |
| FC Provides doula care for pregnant and postpartum patients. | $5.7M | Seed | Healthtech | United States | Investors | |
| C CarecubesCompany profile Develops isolation units to prevent infectious disease transmission in healthcare settings Develops isolation units to prevent infectious disease transmission in healthcare settings | $6.5M | Series A | Healthtech | United States | Investors | |
| P Develops AI agents to automate hospital administrative workflows | $20M | Series A | Healthtech | France | Investors | |
| HU Health UniverseCompany profile Provides AI infrastructure for healthcare organizations to integrate and govern autonomous agents Provides AI infrastructure for healthcare organizations to integrate and govern autonomous agents | $6M | Seed | Healthtech | United States | Investors | |
| ET Excalipoint TherapeuticsCompany profile Develops next-generation T-cell engager therapies for cancer and autoimmune diseases Develops next-generation T-cell engager therapies for cancer and autoimmune diseases | $27.7M | Seed+Seed | Healthtech, Biotech | China | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.